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A B S T R A C T
This report describes two cases of disseminated cutaneous Mycobacterium chelonae after hematopoietic
stem cell transplantation (HSCT).
 2014 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).
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jo u rn al ho m epag e: ww w.els evier . c om / lo cat e/ idc rThis report describes two cases of disseminated cutaneous
Mycobacterium chelonae after hematopoietic stem cell transplan-
tation (HSCT).
Both patients were 57-years-old and received an unrelated
peripheral HSCT for malignant hematologic disease (follicular
lymphoma and myeloﬁbrosis). Both developed chronic graft-
versus-host-disease (cGVHD) and received prolonged systemic
steroids. They subsequently developed multiple erythematous
subcutaneous nodules on legs and arms (eleven months after
transplantation for patient #1 and eighteen months for patient #2;
Fig. 1). Biopsies of subcutaneous nodules revealed a septal
panniculitis with granulomatous components. The Ziehl-Neelsen
stain (Fig. 2) was positive and culture identiﬁed M. chelonae.
Hemocultures were negative.
Patient #1 was treated with a combination of clarythromycin,
tobramycin and tigecycline. The nodules rapidly decreased.
However he died three months later of cardiac failure in a
context of uncontrolled cGVHD and Enterococcus faecium
sepsis. Patient #2 responded well to treatment with azithro-
mycin, imipinem and tobramycin was then given azithromycin
alone.
M. chelonae is a rapidly growing non-tuberculous mycobacteria
isolated from various environmental sources. Water is a major* Corresponding author. Tel.: +33 1 40 50 59 82; fax: +33 1 40 50 53 34.
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described in the setting of immunosuppression and particularly
in patients receiving steroids therapy. After HSCT, M. chelonae
infections are mostly due to central venous catheters or pulmonary
infections, and skin involvement has not yet been described in
previous reports.
In our two patients, prolonged steroid therapy led to skin
atrophy with multiple lesions on limbs. Microbiological
analyses of water of one hospital were performed and were
positive for M. chelonae. As none of the patients had signs
of disseminated infection, it can therefore be hypothesizedFig. 1.
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Fig. 2.
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water used for washing.
In conclusion, cutaneous M. chelonae infection should be
suspected in HSCT recipients developing isolated subcutaneous
nodules in the context of cGVHD.
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